Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia

Completed · Phase 4

Conditions studied: Post-Herpetic Neuralgia

In brief

The purpose of this study is to measure how rapidly pregabalin treatment can relieve pain in patients with post-herpetic neuralgia

Key facts

Study ID

NCT00159666

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

255

Starts

2004-10-01

Expected to finish

2006-06-01

Last updated by the study team

2021-01-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of PHN with pain present for at least three months after the healing of a Herpes Zoster skin lesion.
• Subjects must have completed the Daily Pain Rating Scale in the electronic diary at least 4 times during screening and have an average daily pain rating score of greater than or equl to 4 during the 7 +/- 3 days prior to randomization (Visit 2).

You may not qualify if…

• History of neurolytic or neurosurgical therapy for PHN.
• Presence of any severe pain associated with conditions other than PHN that may confound the assessment or self-evaluation of the pain due to PHN.

Where it is running

• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — Duarte, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Palm Beach Gardens, Florida, United States
• Pfizer Investigational Site — Oak Brook, Illinois, United States
• Pfizer Investigational Site — Flowood, Mississippi, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — Toledo, Ohio, United States
• Pfizer Investigational Site — Portland, Oregon, United States
• Pfizer Investigational Site — Allentown, Pennsylvania, United States
• Pfizer Investigational Site — Houston, Texas, United States
• Pfizer Investigational Site — Seattle, Washington, United States
• Pfizer Investigational Site — Madison, Wisconsin, United States
• Pfizer Investigational Site — Berlin, Germany
• Pfizer Investigational Site — Bochum, Germany
• Pfizer Investigational Site — Düsseldorf, Germany
• Pfizer Investigational Site — Frankfurt, Germany
• Pfizer Investigational Site — Göppingen, Germany
• Pfizer Investigational Site — Hamburg, Germany
• Pfizer Investigational Site — Hattingen, Germany
• Pfizer Investigational Site — Jena, Germany
• Pfizer Investigational Site — Nuremberg, Germany
• Pfizer Investigational Site — Wiesbaden, Germany
• Pfizer Investigational Site — L’Aquila, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.